Skip to main content

Ana Alvarez Guaita

Institutions of which they are part

Postdoctoral researcher
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Ana Alvarez Guaita

Institutions of which they are part

Postdoctoral researcher
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Related news

The work represents a paradigm shift in the clinical approach to this chronic, multifactorial disease, based on the clinical context of each patient and not only on weight loss.

The results of a phase 3 clinical trial show that orforglipron reduces body weight by an average of 11% and improves cardiovascular risk factors.

Dr. Maria Llorián-Salvador, from the Diabetes and Metabolism Research Group at VHIR, is leading this project to identify new therapies for this inherited disease that causes progressive vision loss.

Related professionals

Victoria López Craver

Victoria López Craver

Psychiatry, Mental Health and Addictions
Read more
Montse Perez Fernandez

Montse Perez Fernandez

Research technician
Neurodegenerative Diseases
Read more
Samuel López Maza

Samuel López Maza

Predoctoral researcher
Research Group on Status Epilepticus and Acute Seizures
Read more
Paula Granado Martinez

Paula Granado Martinez

Postdoctoral researcher
Biomedical Research in Melanoma
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.